What is the current Custom Synthetic Genes market size?

The Custom Synthetic Genes market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Custom Synthetic Genes market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driving future outlook.

What are the key drivers of the Custom Synthetic Genes market?

Advances in gene editing technologies and increasing demand for synthetic genes drive market growth.

What are the major challenges facing the Custom Synthetic Genes market?

High development costs and regulatory hurdles are significant challenges in the market.

Which regions are leading the Custom Synthetic Genes market?

North America and Europe are current regional leaders, due to strong research infrastructure.

Who are the top companies in the Custom Synthetic Genes market?

Major players include Thermo Fisher, GenScript, and IDT, offering custom gene synthesis services.

What future opportunities exist in the Custom Synthetic Genes market?

Emerging applications in gene therapy and regenerative medicine offer significant future opportunities.

How is technology impacting the Custom Synthetic Genes market?

Advances in CRISPR and other gene editing tools are transforming the market, enabling efficient synthesis.

What is the current regulatory landscape for the Custom Synthetic Genes market?

Stringent regulations and guidelines govern the market, ensuring safe handling and use of synthetic genes.

Custom Synthetic Genes - Strategic Insights: Analysis 2025 and Forecasts 2033

Custom Synthetic Genes by Application (Commercial, Academic Research), by Types (Below 1000 bp, 1001 - 3000 bp, 3001- 5000 bp, Above 5000 bp), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Custom Synthetic Genes Market Overview

The Custom Synthetic Genes market refers to the industry involved in the design, manufacture, and application of synthetic genes, which are artificially created genes with specific functions. As the Custom Synthetic Genes market size is expected to reach $1.4 billion by 2026, the growth outlook and market forecast indicate a significant expansion of the industry, driven by advancements in genetic engineering and synthetic biology. The industry expansion is anticipated to be fueled by the increasing demand for synthetic genes in various applications, including biotechnology, pharmaceuticals, and agriculture. The scope of the Custom Synthetic Genes market encompasses the development of custom synthetic genes for research, therapeutic, and diagnostic purposes, with a focus on gene editing, gene synthesis, and gene expression.

Loading chart…

The current Custom Synthetic Genes market size is estimated to be around $1.1 billion, with a growth forecast of 15% CAGR from 2026 to 2033. The market is driven by macro drivers such as advancements in technology shifts, regulatory frameworks, and consumer behavior. Key forces shaping the industry include the increasing adoption of CRISPR gene editing, the growing demand for synthetic biology, and the rising competition among market players. The largest region in the Custom Synthetic Genes market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by the increasing investments in biotechnology and genomics.

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	2.68 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Genescript; Thermo Scientific; Twist Bioscience; IDT; DNA 2.0 (ATUM); OriGene; Eurofins Genomics; BBI; Azenta Life Sciences; SBS Genetech; Bio Basic
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Custom Synthetic Genes market is poised for significant growth, driven by advancements in gene synthesis technology and increasing demand for synthetic genes in various applications. The growth forecast for the Custom Synthetic Genes market size is expected to be substantial, with the market expanding at a considerable rate over the forecast period.

Growth Drivers2 items

Advances in gene synthesis technology have improved the efficiency and accuracy of custom synthetic gene production, making it more accessible and affordable for researchers and biotechnology companies. This has led to an increase in the adoption of custom synthetic genes in various fields, including biotechnology, pharmaceuticals, and academia.

The growing demand for synthetic genes in gene therapy, vaccine development, and regenerative medicine has also driven the growth of the Custom Synthetic Genes market. As the demand for these applications continues to rise, the market size is expected to expand, with the growth forecast indicating a significant increase in revenue over the next few years.

Restraints2 items

The high cost of custom synthetic gene synthesis is a significant restraint on the market, as it limits the accessibility of these genes to smaller research institutions and companies with limited budgets. This has led to a slower adoption rate in some regions, affecting the overall Custom Synthetic Genes market size.

Regulatory challenges and intellectual property concerns also pose a restraint on the market, as companies must navigate complex laws and regulations surrounding gene synthesis and editing. This can increase the time and cost associated with bringing custom synthetic genes to market, impacting the growth forecast.

Opportunities2 items

The increasing demand for custom synthetic genes in emerging markets, such as Asia-Pacific and Latin America, presents a significant opportunity for growth. As these regions continue to invest in biotechnology and life sciences research, the Custom Synthetic Genes market size is expected to expand, driven by the growing need for synthetic genes.

The development of new applications for custom synthetic genes, such as biofuels and bioproducts, also presents an opportunity for market growth. As companies explore new uses for synthetic genes, the growth forecast for the Custom Synthetic Genes market is likely to be revised upward, indicating a more substantial increase in revenue.

Challenges2 items

The need for standardized protocols and quality control measures in custom synthetic gene synthesis is a significant challenge facing the market. As the demand for synthetic genes continues to rise, ensuring the quality and consistency of these genes will be crucial to maintaining the growth forecast and expanding the Custom Synthetic Genes market size.

The potential for biosecurity risks and unintended consequences associated with the use of custom synthetic genes is also a challenge that must be addressed. Companies and researchers must work to mitigate these risks and ensure the safe and responsible use of synthetic genes, in order to maintain public trust and support for the Custom Synthetic Genes market.

Market Segmentation

Loading chart…

The Custom Synthetic Genes market can be segmented based on Application, which includes gene therapy, vaccine development, biotechnology research, and diagnostics. Each application contributes to the overall Custom Synthetic Genes market size, with gene therapy and vaccine development being the most prominent ones. The Custom Synthetic Genes segmentation by application is crucial in understanding the market taxonomy and identifying areas of growth.

The Types of Custom Synthetic Genes can be sub-segmented into codon-optimized genes, variant genes, and gene fragments. These subtypes have distinct characteristics and uses, with codon-optimized genes being the most widely used. Understanding the different types of Custom Synthetic Genes is essential for market players to develop targeted strategies and products. The market taxonomy of Custom Synthetic Genes types is complex, and in-depth analysis is required to navigate this segment.

Custom Synthetic Genes Segmentation Breakdown8 items

Application

Commercial

Academic Research

Types

Below 1000 bp

1001 - 3000 bp

3001- 5000 bp

Above 5000 bp

Regional Insights

Loading chart…

The Custom Synthetic Genes market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of custom synthetic genes in research and development activities, favorable policies, and significant investments in the biotechnology sector.

Key drivers for North America include a mature ecosystem, high infrastructure investment, and a large customer base. In Europe, drivers include a strong regulatory framework, increasing demographics of the aging population, and a rise in personalized medicine. Asia Pacific's growth is driven by government initiatives, a large genetically diverse population, and increasing research collaborations. Latin America's growth is driven by emerging economies, while the Middle East & Africa region is driven by strategic partnerships and foreign investments.

The regional forecast indicates a shift in the Custom Synthetic Genes market, with Asia Pacific expected to drive growth due to its large and growing biotechnology industry. As the market continues to evolve, understanding regional trends and drivers will be crucial for stakeholders to capitalize on emerging opportunities and navigate challenges in the Custom Synthetic Genes market.

Competitive Landscape

The Custom Synthetic Genes market structure is moderately consolidated, with a mix of global players and local/regional companies. The Custom Synthetic Genes competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are focusing on product innovation and regulatory approvals to maintain their market position, while local/regional companies are competing on pricing and distribution.

Companies in the Custom Synthetic Genes market are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To overcome these challenges, companies are focusing on technology, service model, channel strength, customization, and cost advantages to differentiate themselves. The following companies are implementing these strategies:

Genescript: regional expansion

Thermo Scientific: innovation pipeline

Twist Bioscience: premium pricing

IDT: OEM tie-ups

DNA 2.0 (ATUM): local manufacturing

OriGene: vertical integration

Key Custom Synthetic Genes Companies11 items

Genescript

Thermo Scientific

Twist Bioscience

IDT

DNA 2.0 (ATUM)

OriGene

Eurofins Genomics

BBI

Azenta Life Sciences

SBS Genetech

Bio Basic

Market Ecosystem

The Custom Synthetic Genes ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers, midstream integrators and channels, to downstream end users. Value creation and capture occur at each stage, from research and development to production and application. Understanding the boundaries and interactions within this ecosystem is crucial for navigating the Custom Synthetic Genes ecosystem.

Raw material/component suppliers — provide genetic material

Technology providers — develop gene synthesis platforms

System integrators / EPCs — design and build gene synthesis systems

Distributors / channel partners — supply synthetic genes to end users

Service providers / after-sales — offer support and maintenance services

End users / buyers — utilize synthetic genes in research and production

Regulators/standards bodies — establish guidelines and standards for synthetic gene use

As value flows through the Custom Synthetic Genes ecosystem, control points emerge, influencing adoption and dependency risks. For instance, regulators and standards bodies can impact the pace of innovation, while technology providers and system integrators may exert control over the supply chain. Furthermore, switching costs, partnerships, and interoperability requirements can create bottlenecks, affecting the overall efficiency of the ecosystem. A thorough value chain analysis is necessary to identify these control points and navigate the complexities of the Custom Synthetic Genes ecosystem, which may differ significantly by region due to varying regulatory frameworks and market conditions.

Recent Industry Insights

The Custom Synthetic Genes industry trends have witnessed significant developments over the last 12-18 months. Recently, there have been notable partnerships between key players, such as the collaboration between Twist Bioscience and Schrodinger to accelerate the discovery of novel therapeutics. Furthermore, the industry has seen a surge in mergers and acquisitions, with Illumina acquiring Grail to enhance its presence in the genomics market.

Additionally, several product and technology launches have taken place, including the introduction of gene editing tools and synthetic biology platforms. Regulatory changes, such as the updated guidelines for gene therapy by the FDA, have also impacted the industry. These developments have contributed to a shift in consumer and enterprise trends, with a growing focus on personalized medicine and precision health. The Custom Synthetic Genes industry is expected to continue evolving, driven by funding rounds, expansions, and advancements in genomics and synthetic biology.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Custom Synthetic Genes market outlook. The market attractiveness is high, driven by increasing demand for synthetic biology and gene editing technologies. The competitive intensity is moderate, with key players focusing on innovation and strategic partnerships. The long-term outlook is positive, with potential applications in various industries, including biotechnology, pharmaceuticals, and agriculture.

The innovation landscape is dynamic, with advancements in gene synthesis, editing, and regulation. However, the demand–supply balance is a key risk factor, as the market is sensitive to fluctuations in demand and supply chain disruptions. Overall, the Custom Synthetic Genes market outlook is promising, with opportunities for growth and development in the coming years.

11 items

1. Executive Summary

2. Custom Synthetic Genes Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Custom Synthetic Genes Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Custom Synthetic Genes Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Commercial

6.1.2. Academic Research

6.2. Global Custom Synthetic Genes Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Below 1000 bp

6.2.2. 1001 - 3000 bp

6.2.3. 3001- 5000 bp

6.2.4. Above 5000 bp

6.3. Global Custom Synthetic Genes Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Custom Synthetic Genes Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Custom Synthetic Genes Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Custom Synthetic Genes Market Competition by Key Manufacturers

8.1. Global Custom Synthetic Genes Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Custom Synthetic Genes: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Genescript

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Thermo Scientific

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Twist Bioscience

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. IDT

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. DNA 2.0 (ATUM)

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. OriGene

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Eurofins Genomics

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. BBI

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Azenta Life Sciences

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. SBS Genetech

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Bio Basic

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Custom Synthetic Genes Market

Figure 4: Global Custom Synthetic Genes Market: Drivers

Figure 5: Global Custom Synthetic Genes Market: Challenges

Figure 6: Global Custom Synthetic Genes Market: Trends

Figure 7: Global Custom Synthetic Genes Market: Opportunity

Figure 8: Global Custom Synthetic Genes Market: Restraint

Figure 9: Global Custom Synthetic Genes Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Custom Synthetic Genes Market Value (USD Million) By Region

Figure 15: Global Custom Synthetic Genes Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Custom Synthetic Genes Market Value (USD Million) By Region

Figure 23: Global Custom Synthetic Genes Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Custom Synthetic Genes Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Custom Synthetic Genes Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Custom Synthetic Genes Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Custom Synthetic Genes Market Value (USD Million) By Region

Table 10: Global Custom Synthetic Genes Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Custom Synthetic Genes Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Custom Synthetic Genes Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Custom Synthetic Genes Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Genescript Basic Information And Sales Area

Table 31: Genescript. Products Portfolio

Table 32: Thermo Scientific Basic Information And Sales Area

Table 33: Thermo Scientific. Products Portfolio

Table 34: Twist Bioscience Basic Information And Sales Area

Table 35: Twist Bioscience. Products Portfolio

Table 36: IDT Basic Information And Sales Area

Table 37: IDT. Products Portfolio

Table 38: DNA 2.0 (ATUM) Basic Information And Sales Area

Table 39: DNA 2.0 (ATUM). Products Portfolio

Table 40: OriGene Basic Information And Sales Area

Table 41: OriGene. Products Portfolio

Table 42: Eurofins Genomics Basic Information And Sales Area

Table 43: Eurofins Genomics. Products Portfolio

Table 44: BBI Basic Information And Sales Area

Table 45: BBI. Products Portfolio

Table 46: Azenta Life Sciences Basic Information And Sales Area

Table 47: Azenta Life Sciences. Products Portfolio

Table 48: SBS Genetech Basic Information And Sales Area

Table 49: SBS Genetech. Products Portfolio

Table 50: Bio Basic Basic Information And Sales Area

Table 51: Bio Basic. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Custom Synthetic Genes Market Value (USD Million) By Region

Table 57: Global Custom Synthetic Genes Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Custom Synthetic Genes Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	2.68 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Genescript; Thermo Scientific; Twist Bioscience; IDT; DNA 2.0 (ATUM); OriGene; Eurofins Genomics; BBI; Azenta Life Sciences; SBS Genetech; Bio Basic
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Custom Synthetic Genes Segmentation Breakdown8 items

Application

Commercial

Academic Research

Types

Below 1000 bp

1001 - 3000 bp

3001- 5000 bp

Above 5000 bp

Regional Insights

Loading chart…

Competitive Landscape

Genescript: regional expansion

Thermo Scientific: innovation pipeline

Twist Bioscience: premium pricing

IDT: OEM tie-ups

DNA 2.0 (ATUM): local manufacturing

OriGene: vertical integration

Key Custom Synthetic Genes Companies11 items

Genescript

Thermo Scientific

Twist Bioscience

IDT

DNA 2.0 (ATUM)

OriGene

Eurofins Genomics

BBI

Azenta Life Sciences

SBS Genetech

Bio Basic

Market Ecosystem

Raw material/component suppliers — provide genetic material

Technology providers — develop gene synthesis platforms

System integrators / EPCs — design and build gene synthesis systems

Distributors / channel partners — supply synthetic genes to end users

Service providers / after-sales — offer support and maintenance services

End users / buyers — utilize synthetic genes in research and production

Regulators/standards bodies — establish guidelines and standards for synthetic gene use

Recent Industry Insights

Analyst Overview

Table of Contents